Gelonghui November 6 | Huilong Co., Ltd. (002556.SZ) said on the investor interactive platform that the company Sun Company Shaohua Biotech is committed to the research and development of raw materials related to the medical and aesthetic industry, focusing on polysaccharides and bioactive proteins. At the same time, the R&D results are applied to products related to our own medical device brand “Helantis” to serve middle and downstream customers in the medical and aesthetic industry.
辉隆股份(002556.SZ)：孙公司韶华生物正致力于医美行业相关原材料的研发，方向以多糖类和生物活性蛋白类为主
Anhui Huilong Agricultural Means of Production (002556.SZ): Its subsidiary Shaohua Biology is dedicated to the research and development of raw materials related to the medical beauty industry, focusing mainly on polysaccharides and bioactive proteins.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated